Patents by Inventor Stephen T. David

Stephen T. David has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5478572
    Abstract: Gepirone compositions having extended release properties contain a gepirone salt, a cellulosic polymer matrix and suitable quantities of pharmaceutical excipients. Dosage forms based thereon require 18 to 24 hours for release of 90 to 95% of gepirone.
    Type: Grant
    Filed: September 6, 1994
    Date of Patent: December 26, 1995
    Assignee: Bristol-Myers Squibb Co.
    Inventors: Stephen T. David, Claude E. Gallian, Joseph C. H. Chou
  • Patent number: 4547358
    Abstract: Non-disintegrating theophylline tablets having a pair of opposing substantially planar surfaces and a very thin cross-section have a high bioavailability on ingestion and a relatively steady release rate permitting a 12 hr. dosing interval for maintenance of non-toxic therapeutic blood theophylline concentrations. Excipients or tableting aids are not required, but trace amounts of a tableting lubricant are preferably included to facilitate continuous large scale production.
    Type: Grant
    Filed: June 4, 1984
    Date of Patent: October 15, 1985
    Assignee: Mead Johnson & Company
    Inventors: Stephen T. David, Dana Brooke, Claude E. Gallian
  • Patent number: 4465660
    Abstract: Non-disintegrating theophylline tablets having a pair of opposing substantially planar surfaces and a very thin cross-section have a high bioavailability on ingestion and a relatively steady release rate permitting a 12 hr. dosing interval for maintenance of non-toxic therapeutic blood theophylline concentrations. Excipients or tableting aids are not required, but trace amounts of a tableting lubricant are preferably included to facilitate continuous large scale production.
    Type: Grant
    Filed: December 21, 1982
    Date of Patent: August 14, 1984
    Assignee: Mead Johnson & Company
    Inventors: Stephen T. David, Dana Brooke, Claude E. Gallian
  • Patent number: 4258027
    Abstract: The invention disclosed provides a multi-fractionable tablet structure initially configurated in a unitary dosage while having readily severable sub-dosage units as components thereof. Score markings are positioned variously about the tablet such as along the top and bottom surfaces thereof. Additionally, score markings may appear along opposite vertical side surfaces of the tablet. Special placement of the score markings readily permits alternatively an accurate equal bisectional or trisectional fracture of the tablet as may be desired for patient consumption.
    Type: Grant
    Filed: February 14, 1980
    Date of Patent: March 24, 1981
    Assignee: Mead Johnson & Company
    Inventors: Michael K. Ullman, Stephen T. David, Claude E. Gallian
  • Patent number: 4215104
    Abstract: The invention disclosed provides a multi-fractionable tablet structure initially configurated in a unitary dosage while having readily severable sub-dosage units as components thereof. Score markings are positioned variously about the tablet both along the top and bottom surfaces of an approximately rectangular configuration whereas in preferred embodiments thereof, score markings additionally appear along opposite vertical side surfaces of the tablet. Special placement of the score markings readily permit at least either an accurate bisectional fracture or accurate trisectional fracture of the tablet as may be desired for patient consumption.
    Type: Grant
    Filed: March 26, 1979
    Date of Patent: July 29, 1980
    Assignee: Mead Johnson & Company
    Inventors: Michael K. Ullman, Stephen T. David, Claude E. Gallian